TCR CURE Biopharma Technology Co., Ltd. (China)

Homepage: tcrcure.com

Alternate names: TCR CURE Biopharma Technology Co., Ltd., TCR Cure Biopharma Technology, TCRCure, TCRCure Biological Technology Co. Ltd., TCRCure Biopharma Corp., TCRCure Biopharma Ltd.

ROR: 020cmkv75

OpenAlex ID: I4405267281

Breaking NGF–TrkA immunosuppression in melanoma sensitizes immunotherapy for durable memory T cell protection

2024 · Tao Yin, Guoping Wang, et al. · Nature Immunology · 59

PDF

EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion

2024 · Yuanyuan Chen, Dijun Ouyang, et al. · Journal for ImmunoTherapy of Cancer · 53

Potential lung attack and lethality generated by EpCAM-specific CAR-T cells in immunocompetent mouse models

2020 · Diyuan Qin, Dan Li, et al. · OncoImmunology · 49

The role of circadian clock in regulating cell functions: implications for diseases

2024 · Yanke Lin, Liangliang He, et al. · MedComm · 40

T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma

2020 · Yang Zhang, Poorva Mudgal, et al. · OncoImmunology · 28

Streamlined Low-Input Transcriptomics through EASY-RNAseq

2019 · Yiwen Zhou, Hao Xu, et al. · Journal of Molecular Biology · 25

PDF

TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma

2021 · Guoping Wang, Poorva Mudgal, et al. · OncoImmunology · 18

A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data

2023 · Zhonghai Du, Tongtong Zhang, et al. · Heliyon · 15

TIPS: trajectory inference of pathway significance through pseudotime comparison for functional assessment of single-cell RNAseq data

2021 · Zihan Zheng, Xin Qiu, et al. · Briefings in Bioinformatics · 15

PDF

The CXCL10‐CXCR3 Axis Induces Tumor‐Associated Neutrophils to Interfere with CTLs‐Mediated Antitumor Activity in EBV‐Associated Epithelial Cancers

2025 · Dijun Ouyang, Tong Xiang, et al. · Advanced Science · 13

Identification of a Novel Prognostic Signature Based on N-Linked Glycosylation and Its Correlation with Immunotherapy Response in Hepatocellular Carcinoma

2023 · Shu-sheng Lin, Ke Zhu, et al. · Journal of Hepatocellular Carcinoma · 11

PDF

Gut microbiota-derived metabolites as novel therapies for inflammatory bowel diseases: Role of nuclear receptors

2024 · Feng Li, Xiaokang Wang, et al. · Fundamental Research · 6

Development of a Novel Pyroptosis-Associated lncRNA Biomarker Signature in Lung Adenocarcinoma

2023 · Peng Wang, Zhiqiang Wang, et al. · Molecular Biotechnology · 6

Breaking boundaries: Current progress of anticancer NK cell-based drug development

2022 · Shuhang Wang, Kun Chen, et al. · Drug Discovery Today · 6

H3.3-K27M neoantigen vaccine elicits anti-tumor T cell immunity against diffuse intrinsic pontine glioma: The phase I ENACTING trial.

2023 · Yang Zhang, Nan Ji, et al. · Journal of Clinical Oncology · 5

TCR-T cells armored with immune checkpoint blockade in EBV-positive nasopharyngeal carcinoma: The first-in-human phase 1/2 trial.

2023 · Qingzhu Jia, Ling Peng, et al. · Journal of Clinical Oncology · 4

The lupus autoantigen La/Ssb is an Xist -binding protein involved in Xist folding and cloud formation

2021 · Norbert Ha, Nan Ding, et al. · Nucleic Acids Research · 4

PDF

scSTATseq: Diminishing Technical Dropout Enables Core Transcriptome Recovery and Comprehensive Single-cell Trajectory Mapping

2020 · Zihan Zheng, Xiangyu Tang, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2

PDF

Abstract CT086: H3.3-K27M neoantigen vaccine elicits CD4+ and CD8+ T cells immunity and improved prognosis against diffuse intrinsic pontine glioma

2023 · Yang Zhang, Nan Ji, et al. · Cancer Research · 1

209 Anti-ALPP CAR-T cell immunotherapy for ovarian and endometrial cancer

2022 · Si Li, Qi-Jing Li, et al. · Journal for ImmunoTherapy of Cancer · 1

PDF

Neoadjuvant anti-4-1BB confers protection against spontaneous metastasis through low-affinity intratumor CD8 + T cells in triple-negative breast cancer

2025 · Bryan Jian Wei Lim, Mingyong Liu, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Works count: 21

Citation count: 762